Adirondack Trust Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.45M | Sell |
13,727
-210
| -2% | -$45.2K | 1.03% | 24 |
|
|
2026
Q1 | $3.03M | Sell |
13,937
-290
| -2% | -$64.3K | 1.02% | 28 |
|
|
2025
Q4 | $3.25M | Sell |
14,227
-345
| -2% | -$78.6K | 1.07% | 20 |
|
|
2025
Q3 | $3.37M | Sell |
14,572
-1,364
| -9% | -$278K | 1.13% | 20 |
|
|
2025
Q2 | $2.96M | Sell |
15,936
-1
| -0% | -$186 | 1.07% | 20 |
|
|
2025
Q1 | $3.34M | Sell |
15,937
-240
| -1% | -$46.7K | 1.3% | 18 |
|
|
2024
Q4 | $2.87M | Sell |
16,177
-63
| -0.4% | -$11.6K | 1.1% | 23 |
|
|
2024
Q3 | $3.21M | Buy |
16,240
+301
| +2% | +$56.2K | 1.24% | 21 |
|
|
2024
Q2 | $2.73M | Sell |
15,939
-49
| -0.3% | -$8.12K | 1.12% | 21 |
|
|
2024
Q1 | $2.91M | Sell |
15,988
-119
| -0.7% | -$20.5K | 1.22% | 19 |
|
|
2023
Q4 | $2.84M | Buy |
16,107
+54
| +0.3% | +$7.87K | 1.23% | 19 |
|
|
2023
Q3 | $2.39M | Buy |
16,053
+107
| +0.7% | +$15.7K | 1.19% | 22 |
|
|
2023
Q2 | $2.39M | Sell |
15,946
-237
| -1% | -$34.8K | 1.11% | 21 |
|
|
2023
Q1 | $2.58M | Buy |
16,183
+34
| +0.2% | +$5.2K | 1.31% | 19 |
|
|
2022
Q4 | $2.61M | Buy |
16,149
+8
| +0% | +$1.23K | 1.35% | 21 |
|
|
2022
Q3 | $2.17M | Buy |
16,141
+91
| +0.6% | +$13.1K | 1.21% | 22 |
|
|
2022
Q2 | $2.46M | Buy |
16,050
+448
| +3% | +$68.5K | 1.32% | 19 |
|
|
2022
Q1 | $2.53M | Buy |
15,602
+1,234
| +9% | +$179K | 1.2% | 22 |
|
|
2021
Q4 | $1.95M | Buy |
14,368
+60
| +0.4% | +$7.09K | 0.93% | 25 |
|
|
2021
Q3 | $1.64M | Buy |
14,308
+86
| +0.6% | +$9.83K | 0.78% | 33 |
|
|
2021
Q2 | $1.6M | Buy |
14,222
+185
| +1% | +$20.8K | 0.81% | 30 |
|
|
2021
Q1 | $1.52M | Buy |
14,037
+875
| +7% | +$93.6K | 0.81% | 30 |
|
|
2020
Q4 | $1.35M | Sell |
13,162
-215
| -2% | -$20.7K | 0.81% | 29 |
|
|
2020
Q3 | $1.17M | Sell |
13,377
-100
| -0.7% | -$9.41K | 0.77% | 32 |
|
|
2020
Q2 | $1.28M | Buy |
13,477
+28
| +0.2% | +$2.46K | 0.85% | 28 |
|
|
2020
Q1 | $1.02M | Buy |
13,449
+710
| +6% | +$60.5K | 0.84% | 31 |
|
|
2019
Q4 | $1.03M | Buy |
12,739
+170
| +1% | +$14.1K | 0.68% | 36 |
|
|
2019
Q3 | $952K | Buy |
12,569
+150
| +1% | +$10.3K | 0.67% | 40 |
|
|
2019
Q2 | $904K | Buy |
12,419
+250
| +2% | +$19.6K | 0.63% | 41 |
|
|
2019
Q1 | $966K | Sell |
12,169
-300
| -2% | -$24.5K | 0.66% | 40 |
|
|
2018
Q4 | $1.15M | Sell |
12,469
-469
| -4% | -$41.2K | 0.89% | 32 |
|
|
2018
Q3 | $1.22M | Buy |
12,938
+350
| +3% | +$33.2K | 0.82% | 32 |
|
|
2018
Q2 | $1.17M | Buy |
12,588
+400
| +3% | +$39.1K | 0.82% | 34 |
|
|
2018
Q1 | $1.18M | Buy |
12,188
+2,478
| +26% | +$272K | 0.84% | 33 |
|
|
2017
Q4 | $939K | Sell |
9,710
-90
| -0.9% | -$8.48K | 0.68% | 41 |
|
|
2017
Q3 | $871K | Buy |
9,800
+65
| +0.7% | +$4.95K | 0.68% | 42 |
|
|
2017
Q2 | $706K | Sell |
9,735
-295
| -3% | -$19.8K | 0.57% | 46 |
|
|
2017
Q1 | $654K | Buy |
10,030
+100
| +1% | +$6.29K | 0.46% | 56 |
|
|
2016
Q4 | $622K | Sell |
9,930
-331
| -3% | -$20.2K | 0.43% | 60 |
|
|
2016
Q3 | $647K | Buy |
10,261
+340
| +3% | +$22K | 0.47% | 55 |
|
|
2016
Q2 | $614K | Sell |
9,921
-1
| -0% | -$61 | 0.44% | 56 |
|
|
2016
Q1 | $566K | Sell |
9,922
-30
| -0.3% | -$1.67K | 0.42% | 58 |
|
|
2015
Q4 | $546K | Sell |
9,952
-975
| -9% | -$56.2K | 0.43% | 58 |
|
|
2015
Q3 | $595K | Sell |
10,927
-125
| -1% | -$8.14K | 0.48% | 55 |
|
|
2015
Q2 | $743K | Buy |
11,052
+445
| +4% | +$29.1K | 0.55% | 46 |
|
|
2015
Q1 | $621K | Buy |
10,607
+1,715
| +19% | +$104K | 0.46% | 55 |
|
|
2014
Q4 | $582K | Sell |
8,892
-335
| -4% | -$21.1K | 0.44% | 57 |
|
|
2014
Q3 | $533K | Sell |
9,227
-100
| -1% | -$5.55K | 0.4% | 61 |
|
|
2014
Q2 | $526K | Hold |
9,327
| – | – | 0.4% | 61 |
|
|
2014
Q1 | $479K | Buy |
9,327
+150
| +2% | +$7.58K | 0.38% | 62 |
|
|
2013
Q4 | $484K | Hold |
9,177
| – | – | 0.39% | 65 |
|
|
2013
Q3 | $410K | Sell |
9,177
-250
| -3% | -$11.1K | 0.36% | 67 |
|
|
2013
Q2 | $390K | Buy |
+9,427
| New | +$412K | 0.35% | 65 |
|
Other funds holding ABBV
Adirondack Trust Company's ABBV Position: Q2 2026 in Review
Adirondack Trust Company reduced its AbbVie (ABBV) stake by 1.5% in Q2 2026, selling an estimated $45.2K and leaving 13,727 shares worth $3.45M. The position accounts for 1.03% of the portfolio, ranked #24.
Adirondack Trust Company first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Adirondack Trust Company held 13,727 shares of AbbVie worth $3.45M as of Q2 2026.
- Adirondack Trust Company sold 210 AbbVie shares in Q2 2026, an estimated $45.2K.
- AbbVie made up 1.03% of Adirondack Trust Company's portfolio in Q2 2026, its #24 holding.
- Adirondack Trust Company first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.